$INO
DD Notes ~ http://www.ddnotesmaker.com/INO
##### recent news/filings ~ source: finance.yahoo.com
Thu, 26 Jun 2014 17:48:18 GMT ~ Is Inovio Poised to Climb, or Will It Tumble?
read full: http://www.fool.com/investing/general/2014/06...lnk0000001
*********************************************************
Mon, 23 Jun 2014 15:17:14 GMT ~ Did Short Sellers In Inovio Listen To The Wrong Piper?
read full: http://seekingalpha.com/article/2281763-did-s...urce=yahoo
*********************************************************
Mon, 23 Jun 2014 08:00:00 GMT ~ Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial
- BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival of its DNA immunotherapy product, INO-3112, in treating human papillomavirus (HPV)-associated cervical cancer. INO-3112 is a combination of Inovio's lead active immunotherapy product, VGX-3100, and its proprietary immune activator expressing interleukin-12 (IL-12). VGX-3100 is currently being evaluated in a randomized phase II efficacy trial for the treatment of high grade cervical dysplasia (pre-cancer). This open-label study, called HPV-004, will evaluate INO-3112 in 20 female subjects with inoperable invasive cervical cancer.
read full: http://finance.yahoo.com/news/inovio-pharmace...00620.html
*********************************************************
Wed, 18 Jun 2014 15:24:32 GMT ~ Inovio Price Volatility: Market-Naive Moves By Management And Confusion Over Scientific Issues
read full: http://seekingalpha.com/article/2274883-inovi...urce=yahoo
*********************************************************
Tue, 17 Jun 2014 08:00:00 GMT ~ Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania
- BLUE BELL, Pa., June 17, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has expanded its existing license agreement with the University of Pennsylvania, adding exclusive worldwide rights to technology and intellectual property for novel synthetic therapies against cancer, infectious diseases and new immune activators. Inovio has an ongoing collaborative research agreement with the university to support fundamental research in the area of DNA-based vaccines and immunotherapies. These new pipeline candidates were developed using Inovio's SynCon® design approach and were constructed and tested in preclinical animal models for their ability to generate potent antigen-specific T cell and antibody responses. Overall, this amendment broadens and strengthens the patent protection around previously licensed oncology and infectious disease targets by in-licensing expanded patents covering candidate products for DNA based synthetic antibodies and those covering dengue fever, H7N9 influenza, additional HPV serotypes as well as certain other undisclosed cancer antigen targets.
read full: http://finance.yahoo.com/news/inovio-pharmace...00253.html
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=INO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=INO&a...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/INO/company-info
Ticker: $INO
OTC Market Place: Not Available
CIK code: 0001055726
Company name: Inovio Pharmaceuticals, Inc.
Company website: http://www.inovio.com/
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/INO/filings
Latest financials: http://www.otcmarkets.com/stock/INO/financials
Latest news: http://www.otcmarkets.com/stock/INO/news - http://finance.yahoo.com/q/h?s=INO+Headlines
Major holdings: http://data.cnbc.com/quotes/INO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=INO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/INO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=INO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Inovio+Pharmaceuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.inovio.com/
Alexa: http://www.alexa.com/siteinfo/http://www.inovio.com/#
Corporate website internet archive: http://web.archive.org/web/*/http://www.inovio.com/
Short Sales: http://www.otcmarkets.com/stock/INO/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/INO/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/INO/research
Historical Prices: http://finance.yahoo.com/q/hp?s=INO+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=INO+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=INO+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=INO+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=INO+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=INO+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=INO
Balance Sheet: http://finance.yahoo.com/q/bs?s=INO
Cash Flow: http://finance.yahoo.com/q/cf?s=INO+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/INO
Bloomberg: http://www.bloomberg.com/quote/INO:US
Morningstar: http://quotes.morningstar.com/stock/s?t=INO
Bussinessweek: http://investing.businessweek.com/research/st...ticker=INO
Barchart: http://www.barchart.com/quotes/stocks/INO
OTC Short Report: http://otcshortreport.com/index.php?index=INO
Investopedia: http://www.investopedia.com/markets/stocks/INO/?wa=0
http://www.pennystocktweets.com/stocks/profile/INO
##### last known share structure ~ source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
The achievements of stimulating the immune system through vaccination have been profound. INO?s synthetic vaccines are designed to treat as well as prevent illnesses, aiming to break the body?s tolerance of cancerous cells and protect against diverse while changing strains of infectious diseases. INO?s SynCon? vaccines are designed to provide universal cross-strain protection against known as well as newly emergent unmatched strains of pathogens such as influenza. These synthetic vaccines, in combination with Inovio's proprietary electroporation delivery, have been shown in humans to generate best-in-class immune responses with a favorable safety profile.Less >>
DD Notes ~ http://www.ddnotesmaker.com/INO